Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Glaucoma Section Editor Nathan Radcliffe, MD, writes about the “chaotic events” that often thwart glaucoma patient care, how he thinks can help his patients become “antifragile,” how they can “grow from unpredictability and chaos.”
New innovations are entering the glaucoma space on a regular basis, but how do physicians discern whether (and when) to adopt them and what is that process like? Two physicians shared their considerations and experiences with bringing new techniques and technologies into practice.
Tube shunts still have important applications for glaucoma patients today and are often used for more severe disease. When categorizing tubes shunts, there are valved or non-valved options. Three physicians discussed the available non-valved tube implants, particularly how a newer option compares to older.
➤ 36- and 48-month efficacy demonstrated with canaloplasty ➤ Phase 1/2 trial for gene therapy for X-linked retinitis pigmentosa ➤ Topline results from Phase 2a trial for possible DME therapy ➤ Preclinical data shows potential for gene therapy to address Leber congenital amaurosis ➤ ASCRS news and events
➤ Topline results from Phase 3 trials of presbyopia-mitigating drop ➤ Study: Long-term visual outcomes of at-home telemonitoring ➤ AAO IRIS Registry Report ➤ Innovations in capsulotomy technology ➤ Complimentary access to video journal ➤ ASCRS news and events
➤ Roberto Zaldivar, MD, delivers the Steinert Lecture ➤ Richard Lindstrom, MD, gives Obstbaum Lecture ➤ Video cases offer a ‘Reay of Hope’ at Glaucoma Day ➤ Cornea Day covers topics in keratoconus, corneal ectasia, lamellar surgery
➤ FDA approves new phaco system ➤ Next-generation canaloplasty device launch ➤ New Nd:YAG laser launch ➤ Researchers explore non-surgical option to address vision loss ➤ Non-invasive method to examine conjunctival goblet cells in vivo ➤ ASCRS news and events
➤ Phase 3 clinical trials complete for ‘superpotent’ corticosteroid ➤ New rapid, quantitative MMP-9 tear test ➤ First pediatric patient dosed with experimental gene-editing therapy for Leber congenital amaurosis ➤ Study: Comparison of NCX 470 to latanoprost for glaucoma ➤ Collaborations for inherited retinal diseases ➤ ASCRS news and events
➤ FDA approves new ICL ➤ Home tonometer receives 510(k) clearance ➤ First patient treated in what will be the largest standalone MIGS clinical trial ➤ Topline results from second Phase 3 trial of mydriasis-reversing drug ➤ ASCRS news and events
➤ Results from pivotal amblyopia trial ➤ Phase 2 clinical program for third-generation keratoconus treatment ➤ Study compares tolerability of standard drop vs. novel drug delivery device ➤ Phase 3 clinical studies for investigational presbyopia drop complete ➤ Orphan drug designation granted for fungal keratitis treatment ➤ Full rights regained for investigational dry AMD therapy ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.